Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia

Pediatric acute myeloid leukemia (AML) represents 20% of total childhood leukemia diagnoses and is characterized by poor prognosis with a long-term survival rate around the 50%, when patients are properly treated. The standard treatment for pediatric AML currently consists in a combination of cytara...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Argenziano, Maura, Tortora, Chiara, Paola, Alessandra Di, Pota, Elvira, Martino, Martina Di, Pinto, Daniela Di, Leva, Caterina Di, Rossi, Francesca
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2021
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274721/
https://ncbi.nlm.nih.gov/pubmed/34262648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.28000
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items